Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone for Spinocerebellar Ataxia (Multicenter Self-controlled Study)
ChiCTR2200060666Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of idebenone in spinocerebellar ataxia (SCA), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Clinical symptom relief. Started Jan 2022; status: recruiting.
02
Drugs
idebenone
03
Conditions
spinocerebellar ataxia (SCA)
Beyond the preview
Go deeper on ChiCTR2200060666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060666.